Dexco Crecimiento futuro
Future controles de criterios 4/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Dexco de 68.7% y 6.9% por año respectivamente. Se prevé que el BPA crezca en un 66.5% al año. Se espera que la rentabilidad financiera sea de 6.3% en 3 años.
Información clave
68.7%
Tasa de crecimiento de los beneficios
66.51%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Forestry | 22.6% |
| Tasa de crecimiento de los ingresos | 6.9% |
| Rentabilidad financiera futura | 6.25% |
| Cobertura de analistas | Good |
| Última actualización | 19 May 2026 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Artículo de análisis • May 18
Dexco's (BVMF:DXCO3) Weak Earnings May Only Reveal A Part Of The Whole Picture
Dexco S.A.'s ( BVMF:DXCO3 ) stock showed strength, with investors undeterred by its weak earnings report. We think that...
Actualización de narrativa • May 02
DXCO3: Future Stock Split Will Support More Attractive Multiple Repricing Outlook
Analysts have raised their price target on Dexco from approximately R$7.16 to about R$7.28, citing updated assumptions regarding the discount rate, revenue growth, profit margins and future P/E multiples. Valuation Changes Fair Value: R$7.16 to R$7.28, representing a small upward adjustment in the modelled target price range.
Actualización de narrativa • Apr 18
DXCO3: Higher Revenue Outlook And Richer Future P/E Will Support Upside
Analysts have raised their valuation of Dexco, increasing the fair value estimate from R$8.70 to R$9.00. The change reflects updated assumptions that include higher revenue growth expectations, a lower discount rate and a richer future P/E multiple, partly offset by a lower projected profit margin.Actualización de narrativa • Apr 04
DXCO3: Future Stock Split Will Support A More Attractive Repricing Outlook
Analysts have slightly adjusted their R$ price target on Dexco, citing updated assumptions that combine a different fair value estimate with changes to revenue growth, profit margin expectations and a higher future P/E multiple. Valuation Changes Fair Value: R$7.22 in the previous model compared with R$7.16 in the updated assumptions.
Actualización de narrativa • Mar 21
DXCO3: Planned Stock Split And Margin Outlook Will Support Future Upside
Analysts have kept their R$ fair value estimate for Dexco steady at R$5.36. Updated assumptions reflect a slightly higher discount rate, a marginally lower revenue growth outlook, a modestly stronger profit margin, and a similar future P/E expectation.Actualización de narrativa • Mar 06
DXCO3: Planned Stock Split Will Support Positive Long Term Outlook
Analysts have revised their R$ price target for Dexco slightly, with the change grounded in updated assumptions that include a different discount rate, adjusted revenue growth and profit margin expectations, and a revised future P/E multiple. What's in the News Dexco plans a stock split or significant stock dividend with a 1.12-for-1 ratio, scheduled for December 26, 2025 (Key Developments).Actualización de narrativa • Feb 20
DXCO3: Future Stock Split Will Support A More Attractive Share Repricing
Analysts have trimmed their R$ price target for Dexco, reflecting a slightly lower fair value estimate alongside updated assumptions for the discount rate, revenue growth, profit margin and future P/E. What's in the News Dexco announced a stock split or significant stock dividend with a 1.12-for-1 ratio, scheduled for December 26, 2025 (Key Developments).Actualización de narrativa • Feb 06
DXCO3: Stock Split And Conservative Earnings Profile Will Support Future Upside
Analysts have reduced their fair value estimate for Dexco from about $8.81 to $8.70 per share. This reflects updated assumptions around discount rates, revenue growth, profit margins and future P/E, which collectively indicate a more conservative earnings profile than previously estimated.Actualización de narrativa • Jan 23
DXCO3: Future Split And Revised Assumptions Will Shape Balanced Outlook
Analysts have reduced their fair value estimate for Dexco from US$6.00 to US$5.36, citing updated assumptions for revenue growth, profit margins, the discount rate, and a lower future P/E multiple. What's in the News Dexco has announced a stock split or significant stock dividend with a 1.12 to 1 ratio, scheduled for December 26, 2025 (Key Developments).Artículo de análisis • Jan 23
Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Actualización de narrativa • Jan 08
DXCO3: Future Margins And Stock Split Plan Will Support Upside
Analysts have adjusted their price target for Dexco, reflecting a fair value change from $9.83 to $8.81. This shift is tied to updated assumptions for revenue growth, profit margins and future P/E expectations.Artículo de análisis • Dec 25
Dexco S.A. (BVMF:DXCO3) Not Flying Under The Radar
With a price-to-earnings (or "P/E") ratio of 41.1x Dexco S.A. ( BVMF:DXCO3 ) may be sending very bearish signals at the...Actualización de narrativa • Dec 23
DXCO3: Stronger Future Margins And Investor Day May Drive Upside
Analysts have adjusted their price target on Dexco from R$10.00 to roughly R$9.83 per share. This reflects slightly lower revenue growth assumptions, stronger expected profit margins, and a more conservative future valuation multiple.Artículo de análisis • Nov 13
Earnings Troubles May Signal Larger Issues for Dexco (BVMF:DXCO3) Shareholders
A lackluster earnings announcement from Dexco S.A. ( BVMF:DXCO3 ) last week didn't sink the stock price. We think that...Artículo de análisis • Oct 06
Does Dexco (BVMF:DXCO3) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Actualización de narrativa • Sep 06
Urbanization Trends And Digital Platforms Will Expand Market Reach
With both revenue growth and net profit margin forecasts holding steady, Dexco’s analyst consensus fair value remains unchanged at R$8.00. Valuation Changes Summary of Valuation Changes for Dexco The Consensus Analyst Price Target remained effectively unchanged, at R$8.00.Artículo de análisis • Mar 21
Dexco's (BVMF:DXCO3) Anemic Earnings Might Be Worse Than You Think
A lackluster earnings announcement from Dexco S.A. ( BVMF:DXCO3 ) last week didn't sink the stock price. Our analysis...Artículo de análisis • Mar 15
Dexco S.A. Just Missed Earnings - But Analysts Have Updated Their Models
Shareholders might have noticed that Dexco S.A. ( BVMF:DXCO3 ) filed its full-year result this time last week. The...
Nueva narrativa • Mar 10
New Ceramic Tiles Factory In Botucatu Will Improve Future Operations
Streamlining of operations could enhance focus on core areas, boosting profitability and improving net margins.Artículo de análisis • Feb 12
Here's Why Dexco (BVMF:DXCO3) Has A Meaningful Debt Burden
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Artículo de análisis • Dec 20
Is Dexco S.A. (BVMF:DXCO3) Potentially Undervalued?
While Dexco S.A. ( BVMF:DXCO3 ) might not have the largest market cap around , it saw significant share price movement...Artículo de análisis • Dec 02
There's Reason For Concern Over Dexco S.A.'s (BVMF:DXCO3) Price
When close to half the companies in Brazil have price-to-earnings ratios (or "P/E's") below 8x, you may consider Dexco...Artículo de análisis • Oct 26
Is Dexco (BVMF:DXCO3) A Risky Investment?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Artículo de análisis • Aug 10
Analysts Are Updating Their Dexco S.A. (BVMF:DXCO3) Estimates After Its Second-Quarter Results
Shareholders of Dexco S.A. ( BVMF:DXCO3 ) will be pleased this week, given that the stock price is up 12% to R$8.05...Artículo de análisis • Aug 08
Why Dexco S.A. (BVMF:DXCO3) Could Be Worth Watching
Dexco S.A. ( BVMF:DXCO3 ), is not the largest company out there, but it saw a decent share price growth of 14% on the...Artículo de análisis • Jul 19
Returns On Capital At Dexco (BVMF:DXCO3) Have Stalled
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...Artículo de análisis • May 13
Earnings Miss: Dexco S.A. Missed EPS And Analysts Are Revising Their Forecasts
Last week saw the newest quarterly earnings release from Dexco S.A. ( BVMF:DXCO3 ), an important milestone in the...Artículo de análisis • May 04
Is It Time To Consider Buying Dexco S.A. (BVMF:DXCO3)?
Dexco S.A. ( BVMF:DXCO3 ), is not the largest company out there, but it saw a double-digit share price rise of over 10...Artículo de análisis • Apr 15
Slowing Rates Of Return At Dexco (BVMF:DXCO3) Leave Little Room For Excitement
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Artículo de análisis • Mar 14
Dexco's (BVMF:DXCO3) Earnings Might Not Be As Promising As They Seem
Shareholders didn't seem to be thrilled with Dexco S.A.'s ( BVMF:DXCO3 ) recent earnings report, despite healthy profit...Artículo de análisis • Jan 19
Dexco S.A.'s (BVMF:DXCO3) Earnings Are Not Doing Enough For Some Investors
With a price-to-earnings (or "P/E") ratio of 7.5x Dexco S.A. ( BVMF:DXCO3 ) may be sending bullish signals at the...Artículo de análisis • Jan 04
Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Artículo de análisis • Dec 04
At R$7.43, Is Dexco S.A. (BVMF:DXCO3) Worth Looking At Closely?
Dexco S.A. ( BVMF:DXCO3 ), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in...Artículo de análisis • Oct 08
Returns Are Gaining Momentum At Dexco (BVMF:DXCO3)
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Artículo de análisis • Sep 13
Is Dexco (BVMF:DXCO3) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2028 | 10,149 | 651 | 1,033 | 1,344 | 5 |
| 12/31/2027 | 9,408 | 533 | 847 | 929 | 10 |
| 12/31/2026 | 8,759 | 289 | 869 | 999 | 4 |
| 3/31/2026 | 8,365 | 9 | 397 | 1,297 | N/A |
| 12/31/2025 | 8,249 | 1 | -69 | 851 | N/A |
| 9/30/2025 | 8,216 | 111 | -6 | 952 | N/A |
| 6/30/2025 | 8,327 | 193 | 44 | 1,104 | N/A |
| 3/31/2025 | 8,201 | 258 | -16 | 1,240 | N/A |
| 12/31/2024 | 8,235 | 172 | -64 | 1,284 | N/A |
| 9/30/2024 | 8,119 | 337 | 86 | 1,482 | N/A |
| 6/30/2024 | 7,649 | 542 | -6 | 1,440 | N/A |
| 3/31/2024 | 7,607 | 602 | 39 | 1,352 | N/A |
| 12/31/2023 | 7,383 | 790 | 98 | 1,346 | N/A |
| 9/30/2023 | 7,415 | 812 | -153 | 975 | N/A |
| 6/30/2023 | 7,808 | 668 | -151 | 993 | N/A |
| 3/31/2023 | 8,068 | 680 | -456 | 726 | N/A |
| 12/31/2022 | 8,487 | 756 | -419 | 794 | N/A |
| 9/30/2022 | 8,757 | 1,128 | 15 | 1,226 | N/A |
| 6/30/2022 | 8,773 | 1,229 | 142 | 1,227 | N/A |
| 3/31/2022 | 8,533 | 1,776 | 550 | 1,505 | N/A |
| 12/31/2021 | 8,170 | 1,725 | 851 | 1,708 | N/A |
| 9/30/2021 | 7,813 | 1,446 | 863 | 1,585 | N/A |
| 6/30/2021 | 7,414 | 1,315 | 1,326 | 1,930 | N/A |
| 3/31/2021 | 6,486 | 574 | 1,289 | 1,813 | N/A |
| 12/31/2020 | 5,880 | 454 | 1,020 | 1,508 | N/A |
| 9/30/2020 | 5,472 | 437 | 1,089 | 1,536 | N/A |
| 6/30/2020 | 5,003 | 341 | 740 | 1,187 | N/A |
| 3/31/2020 | 5,101 | 434 | 578 | 1,050 | N/A |
| 12/31/2019 | 5,012 | 406 | N/A | 1,108 | N/A |
| 9/30/2019 | 4,789 | -21 | N/A | 744 | N/A |
| 6/30/2019 | 4,993 | 327 | N/A | 445 | N/A |
| 3/31/2019 | 5,016 | 425 | N/A | 437 | N/A |
| 12/31/2018 | 4,949 | 432 | N/A | 383 | N/A |
| 9/30/2018 | 4,789 | 658 | N/A | 303 | N/A |
| 6/30/2018 | 4,296 | 365 | N/A | 356 | N/A |
| 3/31/2018 | 4,045 | 223 | N/A | 340 | N/A |
| 12/31/2017 | 3,991 | 185 | N/A | 405 | N/A |
| 9/30/2017 | 3,917 | 125 | N/A | 470 | N/A |
| 6/30/2017 | 3,864 | 72 | N/A | 346 | N/A |
| 3/31/2017 | 3,960 | 47 | N/A | 540 | N/A |
| 12/31/2016 | 3,910 | 24 | N/A | 451 | N/A |
| 9/30/2016 | 3,836 | 50 | N/A | 400 | N/A |
| 6/30/2016 | 3,911 | 48 | N/A | 493 | N/A |
| 3/31/2016 | 3,863 | 85 | N/A | 443 | N/A |
| 12/31/2015 | 3,963 | 183 | N/A | 574 | N/A |
| 9/30/2015 | 4,048 | 221 | N/A | 691 | N/A |
| 6/30/2015 | 4,064 | 275 | N/A | 837 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (68.7% al año) de DXCO3 es superior a la tasa de ahorro (12.4%).
Beneficios vs. Mercado: Se prevé que los beneficios (68.7% al año) de DXCO3 crezcan más rápidamente que el mercado BR (12.6% al año).
Beneficios de alto crecimiento: Se espera que los beneficios de DXCO3 crezcan significativamente en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (6.9% al año) de DXCO3 crezcan más rápidamente que los del mercado BR (6.5% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 6.9% al año) de DXCO3 crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de DXCO3 sea baja dentro de 3 años (6.3%).
Descubre empresas en crecimiento
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/05/21 19:46 |
| Precio de las acciones al final del día | 2026/05/20 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Dexco S.A. está cubierta por 15 analistas. 10 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Guilherme Rosito | BofA Global Research |
| Rafael Barcellos | Bradesco S.A. Corretora de Títulos e Valores Mobiliários |
| Carlos Palhares Sequeira | BTG Pactual |